Oncology
The BIRC service of Pixel Wiser mainly focuses on oncology. Sparkle supports a variety of major oncology drug efficacy assessment criteria, such as RECIST 1.1, Cheson 2007, Lugano 2014, mRECIST, PCWG3, RANO, RANO-BM etc., covering multiple fields such as Solid tumors, Head and Neck cancer, Respiratory cancer, Gastrointestinal cancer and Gynecologic Cancer. Expertise in over 200 BIRC projects for clinical trials, spanning diverse oncology indications and therapeutic classes, including immunotherapeutic antibodies, targeted small-molecule, Cell & Gene Therapies, and XDC interventions. Focus encompasses patient populations across early-stage tumor, first/second-line systemic therapies, and adjuvant/neoadjuvant treatment paradigms.
Founded in 2022.
Pixel Wiser is an Independent Review Committee service provider (IRC) established by an experienced industry team.
Pixel Wiser
Follow Us
Find more about Medical Imaging